Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Polyclonal NF2 Primary Antibody for ICC, IF - ABIN4339287
Zhang, Bai, David, Dong, Zheng, Cai, Giovannini, Liu, Anders, Pan: The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. in Developmental cell 2010
Show all 3 Pubmed References
Human NF2 Primary Antibody for IHC - ABIN966567
Xiao, Gallagher, Shetler, Skele, Altomare, Pestell, Jhanwar, Testa: The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression. in Molecular and cellular biology 2005
Show all 3 Pubmed References
Human Polyclonal NF2 Primary Antibody for IHC - ABIN966568
Ratner, Bryan, Weber, Nguyen, Barnes, Pitt, Gelber, Cheung, Prince: Cystic fibrosis pathogens activate Ca2+-dependent mitogen-activated protein kinase signaling pathways in airway epithelial cells. in The Journal of biological chemistry 2001
Show all 3 Pubmed References
Human Polyclonal NF2 Primary Antibody for IP, IHC - ABIN104130
Wang, Lu, Tang, Wang, Wu: The phosphorylation status of merlin in sporadic vestibular Schwannomas. in Molecular and cellular biochemistry 2009
Show all 2 Pubmed References
Zebrafish (Danio rerio) Polyclonal NF2 Primary Antibody for ELISA - ABIN408735
Sadler, Amsterdam, Soroka, Boyer, Hopkins: A genetic screen in zebrafish identifies the mutants vps18, nf2 and foie gras as models of liver disease. in Development (Cambridge, England) 2005
Human Polyclonal NF2 Primary Antibody for IHC, ELISA - ABIN1532019
Yu, Zeidel, Hill: Cellular expression profile for interstitial cells of cajal in bladder - a cell often misidentified as myocyte or myofibroblast. in PLoS ONE 2012
Show all 3 Pubmed References
Cow (Bovine) Polyclonal NF2 Primary Antibody for WB - ABIN2789402
Vasilyeva, Murzina, Kireev, Pivovarov: Influence of Membrane Receptor Lateral Diffusion on the Short-Term Depression of Acetylcholine-Induced Current in Helix Neurons. in Cellular and molecular neurobiology 2017
Merlin loss increased oxidative stress causing aberrant activation of Hedgehog (show SHH Antibodies) signaling in in vitro.
NF2 promoter gene mutations occurred in medulloblastoma (MB) patients. The NF2 mRNA expression was higher in the controls than in patients; however NF2 protein expression was significantly higher in patients than in the controls. NF2 protein was mainly expressed in the nucleus in MB patients, while the NF2 protein was mainly expressed in the cytoplasm in the controls.
Study summarizes the current knowledge of molecular events triggered by NF2/merlin inactivation, which lead to the development of mesothelioma and other cancers. Genetic alterations in NF2 that abrogate merlin's functional activity are found in about 40% of malignant mesothelioma (MM), indicating the importance of NF2 inactivation in MM development and progression. [review]
Study identified missense NF2 mutations in 1.9% hepatocellular carcinoma (HCC (show FAM126A Antibodies)) and 5.3% intrahepatic cholangiocarcinoma (ICC). Allele frequency of NF2 IVS4-39 A/A was significantly higher in HCCs (show HCCS Antibodies). Also, NF2/Merlin showed a dual role as a tumorigenic gene and tumor-suppressor gene; Merlin was expressed at higher levels in HCC (show FAM126A Antibodies) tumors ; while the rate of Merlin upregulation was lower in poorly differentiated ICCs.
This study demonstrates that simultaneous inhibition of c-Met and Src (show SRC Antibodies) signaling in MD-MSCs triggers apoptosis and reveals vulnerable pathways that could be exploited to develop NF2 therapies.
These results indicate that Merlin/YAP (show YAP1 Antibodies)/cMyc (show MYC Antibodies)/mTOR (show FRAP1 Antibodies) signaling axis promotes human cholangiocarcinoma (CCA (show FBN2 Antibodies)) cell proliferation by overriding contact inhibition. We propose that overriding cMycmediated contact inhibition is implicated in the development of CCA (show FBN2 Antibodies).
The genetic alterations observed in the NF2 gene indicated that spinal schwannomas are associated with genetic alterations also found in other schwannomas and type 2 Neurofibromatosis, which reinforces the etiological role of this gene.
Methylation of NF2 and DNMT1 (show DNMT1 Antibodies) was markedly increased, and miR (show MLXIP Antibodies)-152-3p was downregulated in GBM tissues and glioma cells. Both knockdown of DNMT1 (show DNMT1 Antibodies) and overexpression miR (show MLXIP Antibodies)-152-3p showed that demethylation activated the expression of NF2.
The acquired sensitivity to erlotinib supports the known crosstalk between MET and the HER family of receptors. For the first time, we show inactivation of NF2 during acquisition of resistance to MET-TKI that may explain the refractoriness to erlotinib in these cells.
Genetic data coupled with transcriptomic data allowed the identification of a new malignant pleural mesothelioma (MPM)molecular subgroup, C2(LN), characterized by a co-occurring mutation in the LATS2 and NF2 genes in the same MPM. MPM patients of this subgroup presented a poor prognosis. Coinactivation of LATS2 and NF2 leads to loss of cell contact inhibition between MPM cells
Results demonstrate that loss of merlin function in Schwann Cells (SCs (show TWIST1 Antibodies)) leads to increased endoneurial space and ultrastructural myelin alterations in the sciatic nerve before and after injury. Loss of merlin function in SCs (show TWIST1 Antibodies) delays neural recovery following injury. Nevertheless, there were no significant functional or electrophysiological differences in neural regeneration attributable to Nf2 mutation in SCs (show TWIST1 Antibodies).
Data indicate an essential role for NF2 and the Hippo pathway in regulation of branching morphogenesis in the mammalian kidney.
Loss of Nf2 causes hyperplasia and ocular abnormalities.
studies suggest that NF2 normally limits biliary morphogenesis by coordinating lumen expansion and cell architecture. This work provides fundamental insight into how biliary fate and tubulogenesis are coordinated during development and will guide analyses of disease-associated and experimentally induced biliary pathologies.
Data show that early Smarcb1 (show SMARCB1 Antibodies) loss causes rhabdoid tumors whereas loss at later stages combined with Nf2 gene inactivation causes shwannomas.
Rho attenuates the interaction between Amot (show AMOT Antibodies) and Nf2 by binding to the coiled-coil domain of Amot (show AMOT Antibodies).
co-deletion of Rac1 (show RAC1 Antibodies) with Nf2 blocks tumor initiation but paradoxically exacerbates hepatomegaly induced by Nf2 loss, which can be suppressed either by treatment with pro-oxidants or by co-deletion of Yap (show YAP1 Antibodies).
Merlin controls the repair capacity of Schwann cells after injury by regulating Hippo/YAP (show YAP1 Antibodies) signaling activity.
NF2 is activated by oxidative stress in cardiomyocytes and myocardium and facilitates apoptosis.
loss of axonal contact following nerve injury results in merlin phosphorylation leading to increased p75(NTR (show NGFR Antibodies)) expression.
Mutation of nf2 gene develops extrahepatic choledochal cysts in the common bile duct
NF2/Merlin negatively regulates the Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) signaling activity during the pattern formation in early embryos.
This gene encodes a protein that is similar to some members of the ERM (ezrin, radixin, moesin) family of proteins that are thought to link cytoskeletal components with proteins in the cell membrane. This gene product has been shown to interact with cell-surface proteins, proteins involved in cytoskeletal dynamics and proteins involved in regulating ion transport. This gene is expressed at high levels during embryonic development\; in adults, significant expression is found in Schwann cells, meningeal cells, lens and nerve. Mutations in this gene are associated with neurofibromatosis type II which is characterized by nervous system and skin tumors and ocular abnormalities. Two predominant isoforms and a number of minor isoforms are produced by alternatively spliced transcripts.
, moesin-ezrin-radixin like
, moesin-ezrin-radixin-like protein
, moesin-ezrin-radizin-like protein
, neurofibromin 2 (bilateral acoustic neuroma)
, neurofibromin 2
, neurofibromatosis 2
, LOW QUALITY PROTEIN: merlin
, neurofibromin 2 (merlin) S homeolog